Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay
100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization
COVAXINÒ is the one of the first COVID-19 vaccines in the world to generate data in 2-18 year age group.
Phase II/III, Open-Label, Multi-centre Study was conducted to evaluate the Safety, Reactogenicity, and Immunogenicity of the Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN®) in healthy children
Union Fisheries, Animal Husbandry, and Dairying Minister, Mr. Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out Covid-19 vaccine drug substance in record time.
Indian Immunologicals Ltd (IIL) has quickly responded to the nation’s call and the request of the
With specialised bio safety containment facilities in Hyderabad, Malur, Ankleshwar, and Pune, Bharat Biotech steadily moves towards its aim of ~ 1 billion doses of annualised capacity.
Product manufactured from Ankleshwar facilities will be available for supplies starting September 2021
Bharat Biotech, a global leader in
Dr. Krishna Ella, CMD, Bharat Biotech appreciated the efforts of Doctors’ and support staff during an event to commemorate World Hepatitis Day at KIMS Hospitals
Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech today said that Science and Innovation in India is on par with